Global Polymer Neurovascular Stent Market Size By Type (Carotid artery stents, Intracranial stents), By Application (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2023 to...

The Global Polymer Neurovascular Stent Market was valued at USD 325 million in 2023 and is projected to reach USD 672 million by 2031, growing at a compound annual growth rate (CAGR) of 9.5% during the forecast period from 2023 to 2031. The market is driven by the increasing incidence of neurovascular disorders such as ischemic strokes and aneurysms, along with growing advancements in bioresorbable polymer technologies. Polymer-based stents offer advantages such as reduced inflammatory response, improved biocompatibility, and natural degradation over time, making them a preferred alternative to traditional metal stents.

Drivers:

1. Rise in Neurovascular Diseases:

The increasing prevalence of stroke and related neurological conditions globally is a major factor propelling the market forward. As per WHO, stroke remains a leading cause of disability and death, necessitating advanced treatment options like polymer neurovascular stents.

2. Advancements in Polymer Technologies:

Ongoing innovations in biodegradable polymers used for stents improve patient outcomes by eliminating the need for secondary removal surgeries, minimizing complications, and promoting natural vessel healing.

3. Favorable Regulatory Landscape:

Accelerated approvals by regulatory bodies and growing investment in clinical trials for next-generation neurovascular stents are enhancing the adoption of polymer-based devices.

Restraints:

1. High Development and Manufacturing Costs:

Polymer neurovascular stents are technologically complex and require significant R&D investment, leading to higher production costs and market prices.

2. Limited Awareness and Accessibility in Developing Regions:

In emerging markets, limited awareness among healthcare providers and lack of access to advanced neurovascular treatment limit market penetration.

Opportunity:

1. Growing Geriatric Population:

An aging global population, particularly in developed countries, is more susceptible to neurovascular diseases, creating consistent demand for effective, minimally invasive treatments like polymer stents.

2. Strategic Collaborations and Product Launches:

Collaborations between medical device companies and academic institutions are accelerating innovation. Strategic product launches in untapped markets are expected to create substantial growth opportunities.

Market by System Type Insights:

Based on system type, the Bioresorbable Polymer Stents segment accounted for the largest market share in 2023. These stents are gaining traction due to their capability to dissolve naturally in the body after serving their purpose, eliminating long-term complications associated with permanent implants. Meanwhile, the Coated Polymer Stents segment is expected to exhibit the fastest growth due to their enhanced drug-delivery properties and improved vessel patency rates.

Market by End-use Insights:

In terms of end use, the Hospitals segment emerged as the largest revenue contributor in 2023, driven by the high volume of neurovascular procedures conducted in hospital settings with advanced neurology departments. The Ambulatory Surgical Centers (ASCs) segment is expected to grow at the fastest pace due to increasing preference for outpatient, minimally invasive surgeries and cost-effective care models.

Market by Regional Insights:

Geographically, North America held the largest share in 2023, owing to advanced healthcare infrastructure, high awareness levels, and the presence of leading market players. However, the Asia-Pacific region is expected to witness the highest growth rate through 2031, supported by improving healthcare facilities, rising stroke incidence, and favorable government initiatives promoting medical innovation.

Competitive Scenario:

Key players operating in the Global Polymer Neurovascular Stent Market include:

Stryker Corporation

Medtronic plc

Terumo Corporation

MicroVention Inc. (a subsidiary of Terumo)

Boston Scientific Corporation

BALT Group

Phenox GmbH

Acandis GmbH

Abbott Laboratories

These companies are actively investing in research, clinical trials, and new product launches. For example, in 2024, Stryker announced FDA approval for its next-gen bioresorbable polymer stent, tailored for small intracranial vessels.

Scope of Work – Global Polymer Neurovascular Stent Market

Report Metric Details

Market Size (2023) USD 325 million

Projected Market Size (2031) USD 672 million

CAGR (2023-2031) 9.5%

Market Segments System Type (Bioresorbable, Coated Polymer), End-use (Hospitals, ASCs)

Growth Drivers Rise in neurovascular diseases, technological advancements in polymer stents, supportive regulatory framework

Opportunities Geriatric population growth, product innovation, expanding emerging markets

Key Market Developments:

2024: Medtronic introduced a next-generation polymer stent with enhanced anti-thrombogenic coating.

2023: Boston Scientific collaborated with a European biotech firm to co-develop polymer-based stents for intracranial aneurysms.

2022: Phenox GmbH received CE Mark approval for its polymer neurovascular device, expanding its reach in Europe.

FAQs:

What is the current market size of the Global Polymer Neurovascular Stent Market?

The market size was valued at USD 325 million in 2023.

What is the major growth driver of the Global Polymer Neurovascular Stent Market?

The major driver is the increasing incidence of neurovascular diseases such as strokes and aneurysms.

Which is the largest region during the forecast period in the Global Polymer Neurovascular Stent Market?

North America held the largest market share in 2023.

Which segment accounted for the largest market share in the Global Polymer Neurovascular Stent Market?

The Bioresorbable Polymer Stents segment accounted for the largest share in 2023.

Who are the key market players in the Global Polymer Neurovascular Stent Market?

Key players include Stryker, Medtronic, Boston Scientific, Terumo, and Abbott Laboratories.